文献速递腹部泌尿生殖CT

透明细胞肾细胞癌:基于机器学习的定量CT纹理分析预测Fuhrman核分级

Clear Cell Renal Cell Carcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis for Prediction of Fuhrman Nuclear Grade.
PubMed 文献 · Eur Radiol · 2018-08-30

本回顾性研究纳入53例患者共54个病理证实的透明细胞肾细胞癌(31个低级别,23个高级别),利用门静脉期增强CT提取二维纹理特征,比较SVM、MLP、朴素贝叶斯、k近邻和随机森林等多种机器学习分类器区分低级别与高级别核分级的性能。最佳模型为SVM,总体准确率85.1%,检测高级别cc-RCC的敏感度91.3%、特异度80.6%、AUC 0.860。作者认为基于机器学习的CT纹理分析可能是一种有用的无创预测Fuhrman核分级的方法。

要点

  • SVM模型区分低级别与高级别cc-RCC的总体准确率为85.1%,AUC为0.860。
  • 检测高级别cc-RCC的敏感度为91.3%,特异度为80.6%。
  • 所选纹理特征包括5个共生矩阵、3个游程矩阵、1个梯度和4个Haar小波特征。

核心结论

  • 基于机器学习的CT纹理分析可能是一种有用的、有前景的无创方法,用于预测透明细胞肾细胞癌的低级别与高级别Fuhrman核分级。

研究设计与样本

  • 回顾性研究,纳入53例患者共54个病理证实的cc-RCC(31个低级别[1或2级],23个高级别[3或4级]),1例患者包含两个同时性cc-RCC;平均年龄57.5岁,男性34例(64.1%),女性19例(35.9%);平均肿瘤最大径57.4 mm(范围16-145 mm);40例行根治性肾切除术,13例行部分肾切除术;采用门静脉期增强CT提取二维纹理特征,以病理Fuhrman核分级为参考标准。

关键影像表现/征象

  • 从279个纹理特征中筛选出241个组内相关系数(ICC)≥0.80(可重复性极好)的特征进入进一步特征选择。
  • SVM所选特征子集包括5个共生矩阵特征(ICC范围0.885-0.998)、3个游程矩阵特征(ICC范围0.889-0.992)、1个梯度特征(ICC=0.998)和4个Haar小波特征(ICC范围0.941-0.997)。

诊断标准与关键数值

  • SVM最佳模型检测高级别cc-RCC的总体准确率85.1%、敏感度91.3%、特异度80.6%、总体AUC 0.860。
  • 纹理特征可重复性以ICC≥0.80为纳入标准,241个特征符合。

临床应用与阅片要点

  • 基于机器学习的CT纹理分析可能有助于无创预测cc-RCC的Fuhrman核分级,SVM分类器获得最高预测性能。
  • 原文指出基于经皮穿刺活检文献,基于机器学习的CT纹理分析具有与经皮穿刺活检相当的预测性能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the performance of quantitative computed tomography (CT) texture analysis using different machine learning (ML) classifiers for discriminating low and high nuclear grade clear cell renal cell carcinomas (cc-RCCs).

MATERIALS AND METHODS: This retrospective study included 53 patients with pathologically proven 54 cc-RCCs (31 low-grade [grade 1 or 2]; 23 high-grade [grade 3 or 4]). In one patient, two synchronous cc-RCCs were included in the analysis. Mean age was 57.5 years. Thirty-four (64.1%) patients were male and 19 were female (35.9%). Mean tumour size based on the maximum diameter was 57.4 mm (range, 16-145 mm). Forty patients underwent radical nephrectomy and 13 underwent partial nephrectomy. Following pre-processing steps, two-dimensional CT texture features were extracted using portal-phase contrast-enhanced CT. Reproducibility of texture features was assessed with the intra-class correlation coefficient (ICC). Nested cross-validation with a wrapper-based algorithm was used in feature selection and model optimisation. The ML classifiers were support vector machine (SVM), multilayer perceptron (MLP, a sort of neural network), naïve Bayes, k-nearest neighbours, and random forest. The performance of the classifiers was compared by certain metrics.

RESULTS: Among 279 texture features, 241 features with an ICC equal to or higher than 0.80 (excellent reproducibility) were included in the further feature selection process. The best model was created using SVM. The selected subset of features for SVM included five co-occurrence matrix (ICC range, 0.885-0.998), three run-length matrix (ICC range, 0.889-0.992), one gradient (ICC = 0.998), and four Haar wavelet features (ICC range, 0.941-0.997). The overall accuracy, sensitivity (for detecting high-grade cc-RCCs), specificity (for detecting high-grade cc-RCCs), and overall area under the curve of the best model were 85.1%, 91.3%, 80.6%, and 0.860, respectively.

CONCLUSIONS: The ML-based CT texture analysis can be a useful and promising non-invasive method for prediction of low and high Fuhrman nuclear grade cc-RCCs.

KEY POINTS: • Based on the percutaneous biopsy literature, ML-based CT texture analysis has a comparable predictive performance with percutaneous biopsy. • Highest predictive performance was obtained with use of the SVM. • SVM correctly classified 85.1% of cc-RCCs in terms of nuclear grade, with an AUC of 0.860.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Bektas CT, Kocak B, Yardimci AH, et al. Clear Cell Renal Cell Carcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis for Prediction of Fuhrman Nuclear Grade. Eur Radiol. 2018. PMID: 30167812. doi:10.1007/s00330-018-5698-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。